Charles Albright's Insider Trades & SAST Disclosures
Charles Albright's most recent trade in Editas Medicine Inc was a trade of 10,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 15, 2020.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Charles Albright.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 10,000 | 145,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.51 per share. | 15 Dec 2020 | 10,000 | 34,907 (0%) | 0% | 16.5 | 165,100 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 62.74 per share. | 15 Dec 2020 | 5,776 | 29,131 (0%) | 0% | 62.7 | 362,386 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 63.84 per share. | 15 Dec 2020 | 4,024 | 25,107 (0%) | 0% | 63.8 | 256,892 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 64.39 per share. | 15 Dec 2020 | 200 | 24,907 (0%) | 0% | 64.4 | 12,878 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.51 per share. | 09 Dec 2020 | 10,000 | 34,907 (0%) | 0% | 16.5 | 165,100 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2020 | 10,000 | 155,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 09 Dec 2020 | 10,000 | 24,907 (0%) | 0% | 45 | 450,000 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 40.02 per share. | 07 Dec 2020 | 20,000 | 24,907 (0%) | 0% | 40.0 | 800,400 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 20,000 | 165,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.51 per share. | 07 Dec 2020 | 20,000 | 44,907 (0%) | 0% | 16.5 | 330,200 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.39 per share. | 15 Oct 2020 | 3,000 | 25,135 (0%) | 0% | 31.4 | 94,170 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.51 per share. | 17 Aug 2020 | 10,000 | 38,135 (0%) | 0% | 16.5 | 165,100 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.29 per share. | 17 Aug 2020 | 10,000 | 28,135 (0%) | 0% | 35.3 | 352,900 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 10,000 | 185,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 10,000 | 195,000 | - | - | Stock Option (right to buy) | |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.51 per share. | 06 Aug 2020 | 10,000 | 38,373 (0%) | 0% | 16.5 | 165,100 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 37.47 per share. | 06 Aug 2020 | 10,000 | 28,373 (0%) | 0% | 37.5 | 374,700 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 34.99 per share. | 06 Aug 2020 | 238 | 28,135 (0%) | 0% | 35.0 | 8,328 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.22 per share. | 15 Jul 2020 | 3,000 | 28,373 (0%) | 0% | 32.2 | 96,660 | Common Stock |
| Editas Medicine Inc | Charles Albright | EVP/Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.28 per share. | 06 May 2020 | 151 | 31,373 (0%) | 0% | 25.3 | 3,817 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges